ESPE Abstracts Search

Use the keyword text box above to search across all volumes for abstracts and authors.
You can filter the results by adjusting the search options under 'filter search results'.
Use the advanced search options to limit or expand the scope of the results found.

Showing page 1 of results 1 - 10 of about 10 pages

100% match
2 hit(s)
HTML
39kb

Burosumab Resulted in Better Clinical Outcomes Than Continuation with Conventional Therapy in Both Younger (1-4 Years-Old) and Older (5-12 Years-Old) Children with X-Linked Hypophosphatemia | ESPE2019
Wolfgang Högler; Erik A. Imel; Michael P. Whyte; Craig Munns; Anthony A. Portale; Leanne Ward; Ola Nilsson; Jill H. Simmons; Ra
http://abstracts.eurospe.org/hrp/0092/hrp0092RFC2.1
Published: 2019-08-22

100% match
2 hit(s)
HTML
37kb

Benefits of Long-Term Burosumab Persist in 11 Girls with X-Linked Hypophosphatemia (XLH) Who Transitioned into Adolescence During the Phase 2 CL201 Trial | ESPE2019
Annemieke Boot; Thomas O. Carpenter; Wolfgang Högler; Erik A. Imel; Anthony A. Portale; Agnès Linglart; Raja Padidela; Hoff Wi
http://abstracts.eurospe.org/hrp/0092/hrp0092FC2.2
Published: 2019-08-22

100% match
2 hit(s)
HTML
37kb

100% match
2 hit(s)
HTML
39kb

100% match
2 hit(s)
HTML
37kb

100% match
2 hit(s)
HTML
39kb

Burosumab Improved Rickets, Phosphate Metabolism, and Clinical Outcomes Compared to Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) - A Randomized Controlled Phase 3 Study | ESPE2018
Ola Nilsson; Michael P. Whyte; Erik A. Imel; Craig Munns; Anthony A. Portale; Leanne Ward; Jill H. Simmons; Raja Padidela; Noriy
http://abstracts.eurospe.org/hrp/0089/hrp0089fc10.1.htm
Published: 2018-08-28

100% match
2 hit(s)
HTML
36kb

Burosumab, a Fully Human anti-FGF23 Monoclonal Antibody, for X-linked Hypophosphatemia (XLH): Sustained Improvement in two Phase 2 Trials in Affected Children 1-12 years old | ESPE2018
Agnes Linglart; Michael P. Whyte; Erik Imel; Anthony A. Portale; Annemieke Boot; Wolfgang Hogler; Raja Padidela; Meng Mao; Aliso
http://abstracts.eurospe.org/hrp/0089/hrp0089fc2.1.htm
Published: 2018-08-28

100% match
2 hit(s)
HTML
37kb

Effect of KRN23, a Fully Human Anti-FGF23 Monoclonal Antibody, on Rickets in Children with X-linked Hypophosphatemia (XLH): 40-week Interim Results from a Randomized, Open-label Phase 2 Study | ESPE2016
Agnes Linglart; Thomas Carpenter; Erik Imel; Annemieke Boot; Wolfgang Hogler; Raja Padidela; Michael Whyte; Chao-Yin Chen; Aliso
http://abstracts.eurospe.org/hrp/0086/hrp0086fc2.6.htm
Published: 2016-08-19

100% match
2 hit(s)
HTML
32kb

Online Survey to Characterise the Burden of Illness in Children with X-Linked Hypophosphatemia | ESPE2015
Agnes Linglart; Melita Dvorak-Ewell; Ayla Marshall; Javier San Martin; Alison Skrinar
http://abstracts.eurospe.org/hrp/0084/hrp0084p2-228.htm
Published: 2015-08-26